| Theresa G Jackson, MD | |
|
3640 High St, Suite 2a, Portsmouth, VA 23707-3213 | |
| (757) 397-6930 | |
| (757) 397-4864 |
| Full Name | Theresa G Jackson |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 35 Years |
| Location | 3640 High St, Portsmouth, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245239227 | NPI | - | NPPES |
| 005602785 | Medicaid | VA | |
| 080007399 | Other | VA | MEDICARE INDIVIDUAL PROVIDER ID |
| P00799688 | Other | VA | RR MEICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0101050002 (Virginia) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | 0101050002 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bon Secours Maryview Medical Center | Portsmouth, VA | Hospital |
| Sentara Obici Hospital | Suffolk, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bon Secours Medical Group Hampton Roads Specialty Care Llc | 3173955671 | 165 |
| Ivyrehab Sept, Llc | 7911990908 | 1137 |
News Archive
If you hate going to the dentist, here's some good news. New research published online in The FASEB Journal, shows that melanocortin agonism may effectively control the inflammation that often occurs in gum tissue, which when unchecked, ultimately accelerates tooth and bone loss.
A team of researchers from Inserm led by Paul Hofman (Inserm Unit 1081/University of Nice) has just made a significant advance in the area of early diagnosis of invasive cancers. In a study which has just been published in the journal PLOS ONE, the team shows that it is possible to detect, in patients at risk of developing lung cancer, early signs, in the form of circulating cancer cells, several months, and in some cases several years, before the cancer becomes detectable by CT scanning.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that results from a United States Pharmacopeia Preservative Efficacy Test (USP PET) qualified NexACT as an anti-microbial preservative. The results show that NexACT was effective in killing more than 23 strains of bacteria, fungus and mold, well beyond the requirements for passing the USP PET.
Hemispherx Biopharma, Inc. today announced that, as result of court mediation proceedings, it has entered into a written agreement in principle with the Court-appointed lead plaintiffs to settle all of the currently pending securities class actions consolidated in the U.S. District Court for the Eastern District of Pennsylvania.
› Verified 3 days ago
| Entity Name | Bon Secours Medical Group Hampton Roads Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629637475 PECOS PAC ID: 3173955671 Enrollment ID: O20191122000258 |
News Archive
If you hate going to the dentist, here's some good news. New research published online in The FASEB Journal, shows that melanocortin agonism may effectively control the inflammation that often occurs in gum tissue, which when unchecked, ultimately accelerates tooth and bone loss.
A team of researchers from Inserm led by Paul Hofman (Inserm Unit 1081/University of Nice) has just made a significant advance in the area of early diagnosis of invasive cancers. In a study which has just been published in the journal PLOS ONE, the team shows that it is possible to detect, in patients at risk of developing lung cancer, early signs, in the form of circulating cancer cells, several months, and in some cases several years, before the cancer becomes detectable by CT scanning.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that results from a United States Pharmacopeia Preservative Efficacy Test (USP PET) qualified NexACT as an anti-microbial preservative. The results show that NexACT was effective in killing more than 23 strains of bacteria, fungus and mold, well beyond the requirements for passing the USP PET.
Hemispherx Biopharma, Inc. today announced that, as result of court mediation proceedings, it has entered into a written agreement in principle with the Court-appointed lead plaintiffs to settle all of the currently pending securities class actions consolidated in the U.S. District Court for the Eastern District of Pennsylvania.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Theresa G Jackson, MD 3640 High St, Suite 2a, Portsmouth, VA 23707-3213 Ph: (757) 397-6930 | Theresa G Jackson, MD 3640 High St, Suite 2a, Portsmouth, VA 23707-3213 Ph: (757) 397-6930 |
News Archive
If you hate going to the dentist, here's some good news. New research published online in The FASEB Journal, shows that melanocortin agonism may effectively control the inflammation that often occurs in gum tissue, which when unchecked, ultimately accelerates tooth and bone loss.
A team of researchers from Inserm led by Paul Hofman (Inserm Unit 1081/University of Nice) has just made a significant advance in the area of early diagnosis of invasive cancers. In a study which has just been published in the journal PLOS ONE, the team shows that it is possible to detect, in patients at risk of developing lung cancer, early signs, in the form of circulating cancer cells, several months, and in some cases several years, before the cancer becomes detectable by CT scanning.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that results from a United States Pharmacopeia Preservative Efficacy Test (USP PET) qualified NexACT as an anti-microbial preservative. The results show that NexACT was effective in killing more than 23 strains of bacteria, fungus and mold, well beyond the requirements for passing the USP PET.
Hemispherx Biopharma, Inc. today announced that, as result of court mediation proceedings, it has entered into a written agreement in principle with the Court-appointed lead plaintiffs to settle all of the currently pending securities class actions consolidated in the U.S. District Court for the Eastern District of Pennsylvania.
› Verified 3 days ago
Mrs. Joan L Redd, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3636 High St, Portsmouth, VA 23707 Phone: 757-398-4160 Fax: 757-398-7312 | |
Ivan D Hinnant, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Navy Medical Center, Portsmouth, VA 23708 Phone: 757-953-1416 | |
David Daniel Alcantara, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1040 University Blvd, Mast One Suite 200, Portsmouth, VA 23703 Phone: 757-397-6930 Fax: 757-393-4864 | |
Anna-christina Bevelaqua, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1040 University Blvd Ste 200, Portsmouth, VA 23703 Phone: 757-397-6930 Fax: 757-393-4864 | |
Reeta M Arora, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3640 High St, Ste 2a, Portsmouth, VA 23707 Phone: 757-397-6930 Fax: 757-397-4864 |